Table 1.
Protein kinase inhibitors exhibiting inhibitory effects on DENV infection
| Inhibitor | Src | Abl | c-Kit, PDGFR, VEGFR | Other kinase targets | Pre | Post |
|---|---|---|---|---|---|---|
| K002 | CDKs | X | ||||
| K014 (Imatinib) | X | X | X | |||
| K039 | c-Raf | X | ||||
| K040 | JAK1, -2, -3 | X | ||||
| K003 | X | X | X | X | X | |
| K013 (GNF2) | X | X | X | |||
| K030 | X | Kdr | X | X | ||
| K032 | CK II | X | X | |||
| K117 | X | X | X | |||
| K045 (AZD0530) | X | X | X | |||
| K005 (Dasatinib) | X | X | X | X | ||
| K025 (SU11652) | X | FGFR | X | |||
| K028 (Lavendustin A) | X | EGFR | X | |||
| K026 (SU5271) | EGFR | X | ||||
| K144 (Kenpaullone) | X | CDKs, GSK3-b | X | |||
| K115 (Lavendustin C) | X | CaMK II | X | |||
| K116 (MC7) | MLCK | X | ||||
| K118 (Tyrphostin46) | X | X | X | Multi-targeted | X |